Join the Respiratory Syncytial Virus group to help and get support from people like you.
Respiratory Syncytial Virus News (Page 2)
Related terms: Bronchiolitis, RSV
Real-World Study Confirms RSV Vaccine's, Arexvy and Abrysvo, Protective Power for Seniors
FRIDAY, Oct. 18, 2024 – A global real-world study of the vaccine for respiratory syncytial virus (RSV) finds it offers folks aged 60 and over 80% protection against severe illness and/or...
IDSA: Vaccination Less Likely With Increasing Social Vulnerability, Black Race
FRIDAY, Oct. 18, 2024 – Vaccination for influenza, severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), and respiratory syncytial virus (RSV) is less likely with an increasing social...
Poll Finds Public Fears Over RSV Have Eased, Although It Remains a Threat
WEDNESDAY, Oct. 16, 2024 – Public concerns about contracting RSV (respiratory syncytial virus) have significantly declined during the past year, a new survey shows. About 1 in 4 people (26%) are now...
More Than Half of Infants Protected by Maternal RSV Vaccine, Nirsevimab, or Both
FRIDAY, Sept. 27, 2024 – In the 2023 to 2024 respiratory syncytial virus (RSV) season, more than half of infants were protected by maternal RSV vaccine, nirsevimab, or both, according to research...
Ziresovir Reduces Signs, Symptoms of Bronchiolitis in Babies With RSV
FRIDAY, Sept. 27, 2024 – For infants and young children hospitalized with respiratory syncytial virus (RSV) infection, ziresovir reduces signs and symptoms of bronchiolitis, according to a study...
RSV Vaccination Effective Against Hospitalization in Patients 60 Years and Older
THURSDAY, Sept. 5, 2024 – For older adults, respiratory syncytial virus (RSV) vaccination is effective against RSV hospitalization, according to a study published online Sept. 4 in the Journal of...
RSV Infection With Inflammatory Bowel Disease Ups Risk for Hospitalization
WEDNESDAY, Aug. 28, 2024 – Adult patients with inflammatory bowel disease (IBD) and respiratory syncytial virus (RSV) infection have an increased risk for hospitalization, according to a study...
Wearing Face Mask Reduces Risk for Symptoms of Respiratory Infection
WEDNESDAY, July 31, 2024 – Wearing a surgical mask in public spaces is associated with a reduced risk for self-reported symptoms consistent with a respiratory infection, according to a study...
Nirsevimab Effective Against RSV-Linked Bronchiolitis Hospitalization
WEDNESDAY, July 10, 2024 – Nirsevimab therapy is effective for reducing the risk for hospitalization for respiratory syncytial virus (RSV)-associated bronchiolitis among infants, according to a...
Study Shows RSV Vaccine Abrysvo, Safe in Late Pregnancy
TUESDAY, July 9, 2024 – Expectant mothers who get vaccinated to protect their newborns against respiratory syncytial virus (RSV) are not putting themselves or their babies at risk, new research...
CDC Strengthens RSV Vaccine Advice for Those Over 75
THURSDAY, June 27, 2024 – In new vaccination guidance issued Wednesday, U.S. health officials now recommend that all Americans aged 75 and older get an RSV vaccine before fall arrives. However,...
Marked Increase in Pediatric RSV Hospitalizations Seen Postpandemic
TUESDAY, June 18, 2024 – Hospital volumes for pediatric respiratory syncytial virus (RSV) rose significantly following the pandemic, along with the need for advanced respiratory support in older...
FDA Gives Nod to RSV Vaccine, Arexvy, for People in Their 50s
MONDAY, June 10, 2024 – The U.S. Food and Drug Administration on Friday has for the first time approved the use of a respiratory syncytial virus (RSV) vaccine for people in their 50s who are at...
FDA Approves mRESVIA (respiratory syncytial virus vaccine) for Prevention of Lower Respiratory Tract Disease Caused by RSV
CAMBRIDGE, MA / ACCESSWIRE / May 31, 2024 / Moderna, Inc. (NASDAQ:MRNA) today announced that the U.S. Food and Drug Administration (FDA) has approved mRESVIA (mRNA-1345), an mRNA respiratory...
Personalized Tool Can Predict Infants at Increased Risk for RSV
THURSDAY, May 9, 2024 – A personalized tool can predict infants at increased risk for severe respiratory syncytial virus (RSV) lower respiratory tract infection (LRTI) who would benefit most from...